Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
BioLargo, Inc. (BLGO) had Consolidated Net Income/Loss of $-1.88M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.78M |
|
$-1.19M |
|
$1.36M |
|
$1.42M |
|
$4.58M |
|
$-1.80M |
|
$-0.08M |
|
$-1.88M |
|
$-1.88M |
|
$-1.88M |
|
$-1.88M |
|
|
Consolidated Net Income/Loss |
$-1.88M |
$-1.88M |
|
$-1.80M |
|
$-1.67M |
|
303.20M |
|
303.20M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$9.19M |
|
$1.66M |
|
$3.31M |
|
$12.50M |
|
$4.08M |
|
$1.49M |
|
$2.36M |
|
$6.44M |
|
$6.06M |
|
$6.06M |
|
$6.06M |
|
306.75M |
|
| Cash Flow Statement Financials | |
$-3.95M |
|
$0.19M |
|
$3.70M |
|
$3.55M |
|
$3.47M |
|
$-0.08M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.25 |
|
-- |
|
-- |
|
0.20 |
|
0.44 |
|
51.17% |
|
-64.89% |
|
-64.89% |
|
-- |
|
-67.77% |
|
-42.92% |
|
$-3.95M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
3.05 |
|
1.60 |
|
56.23 |
|
-31.06% |
|
-31.06% |
|
-15.06% |
|
-24.94% |
|
$0.02 |
|
$-0.01 |
|
$-0.01 |
|